𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Controlled Trial Comparing 2 Different Starting Doses of Methotrexate in Rheumatoid Arthritis

✍ Scribed by Dhir, Varun; Singla, Mandeep; Gupta, Nidhi; Goyal, Palvi; Sagar, Vinay; Sharma, Aman; Khanna, Shefali; Singh, Surjit

Book ID
125828402
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
280 KB
Volume
36
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dose escalation of parenteral methotrexa
Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial
✍ C. Michael Lambert; Sharron Sandhu; Alison Lochhead; Nigel P. Hurst; Euan McRori πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Abstract ## Objective To examine whether dose escalation of intramuscular (IM) methotrexate (MTX) up to 45 mg/week improves disease control in patients who have active rheumatoid arthritis (RA) despite receiving conventional doses (15 mg/week) of IM MTX, and to obtain preliminary data on patien

Combination of infliximab and methotrexa
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
✍ E. William St. Clair; DΓ©sirΓ©e M. F. M. van der Heijde; Josef S. Smolen; Ravinder πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 2 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor Ξ± [anti‐TNFΞ±] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≀3 years' duration. ## Methods RA patient